Hospira gets OK to market generic Taxotere
LAKE FOREST, Ill. — Hospira has received approval from the Food and Drug Administration for a generic cancer treatment.
Hospira will offer 20-mg, 80-mg and 160-mg vials of docetaxel at a 10-mg/mL concentration. Docetaxel is a generic version of Sanofi-Aventis’s Taxotere.
Hospira already markets docetaxel in Europe and Australia, the drug maker noted.
"Hospira’s docetaxel will give U.S. cancer patients access to a high-quality, lower-cost alternative to the branded product, [will offer] a differentiated delivery system designed to enhance caregiver safety and [will reinforce] Hospira’s commitment to meet patient and caregiver needs in the oncology space," said Thomas Moore, president, U.S. for Hospira.
U.S. sales of Taxotere were approximately $1.2 billion in 2010, Hospira said.
NCPA emphasizes Dispose My Meds program during Patient Safety Awareness Week
ALEXANDRIA, Va. — In line with Patient Safety Awareness Week, which began Sunday, the National Community Pharmacists Association is encouraging patients to properly dispose of their expired or unused medications safely and effectively.
The NCPA’s Dispose My Meds program, which was developed with Sharps Compliance, gives patients an effective solution to dealing with outdated prescriptions. By logging on to the Dispose My Meds website, consumers can find participating pharmacies by city, state or zip code to dispose of unused medications, excluding controlled substances.
“Pharmacists can help patients monitor what medications are taken, how they interact with other drugs, how effective they are and what side effects they might cause as a way to ensure maximum results,” said Robert Greenwood, NCPA president and pharmacy owner. “During Patient Safety Awareness Week, and anytime, we encourage patients to talk to their community pharmacists about medication safety and how to dispose of medications properly when they go unused or expire.”
To learn more, visit DisposeMyMeds.org.
Third annual NACDS RxImpact Day in full swing
ALEXANDRIA, Va. — Capitol Hill will turn into a sea of white lab coats Wednesday and Thursday as more than 350 pharmacy advocates from almost 40 states visit Washington for the third annual National Association of Chain Drug Stores RxImpact Day, NACDS said Wednesday.
The event will include pharmacy and retail executives, division and store managers, pharmacists, pharmacy school deans and students advocating on behalf of pharmacy to members of Congress.
“NACDS RxImpact Day on Capitol Hill demonstrates the excitement, enthusiasm and active engagement of pharmacy — the face of neighborhood health care,” NACDS president and CEO Steve Anderson said. “In the third year of this well-attended event, NACDS RxImpact Day continues to build momentum for pro-patient and pro-pharmacy public policy, and is a strong testament to pharmacy’s future health and well-being.”
In addition to RxImpact Day itself, NACDS also sponsors training sessions to teach participants how to advocate on behalf of pharmacy to lawmakers, tours of pharmacies for members of Congress that expose them to how pharmacists help patients improve their health, and action alerts designed to influence advocates when issues emerge.